Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema

NCT: NCT07086339 · RECRUITING

NCT IDNCT07086339
StatusRECRUITING
Start Date2026-02-04
Completion2027-12
SponsorPulmair Medical, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

A Study at Two Hospitals Testing the Safety and Effectiveness of the IAB 50 Flex, a New Implant for Adults with Severe COPD or Emphysema

Frequently Asked Questions

What is A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema?

A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema is a clinical trial registered under NCT07086339. Current status: RECRUITING.

What is the status of NCT07086339?

The current status of NCT07086339 (A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema) is: RECRUITING.

When did A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema start?

A Trial of the Implantable Artificial Bronchus 50 Flex in Patients With Severe Emphysema started on 2026-02-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑